Chlorpheniramine Maleate; Codeine Phosphate Patent Expiration
Chlorpheniramine Maleate; Codeine Phosphate is Used for treating cough and symptoms of upper respiratory allergies or the common cold. It was first introduced by Mainpointe Pharmaceuticals Llc
Chlorpheniramine Maleate; Codeine Phosphate Patents
Given below is the list of patents protecting Chlorpheniramine Maleate; Codeine Phosphate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tuxarin Er | US9066942 | Oral dosage forms for oxygen-containing active agents and oxyl-containing polymer | Jan 03, 2032 | Mainpointe |
| Tuxarin Er | US9107921 | Oral dosage forms for oxygen containing active agents and oxyl-containing polymers | Jan 03, 2032 | Mainpointe |
| Tuxarin Er | US6248363 | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
Nov 23, 2019
(Expired) | Mainpointe |
| Tuxarin Er | US6383471 | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
Apr 06, 2019
(Expired) | Mainpointe |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Chlorpheniramine Maleate; Codeine Phosphate's patents.
Latest Legal Activities on Chlorpheniramine Maleate; Codeine Phosphate's Patents
Given below is the list recent legal activities going on the following patents of Chlorpheniramine Maleate; Codeine Phosphate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 08 Feb, 2023 | US9107921 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 01 Dec, 2022 | US9066942 |
| Surcharge for late Payment, Small Entity | 02 Jan, 2019 | US9066942 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 02 Jan, 2019 | US9066942 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 30 Nov, 2018 | US9107921 |
| Application ready for PDX access by participating foreign offices Critical | 31 Aug, 2015 | US9066942 |
| Application ready for PDX access by participating foreign offices Critical | 31 Aug, 2015 | US9107921 |
| Patent Issue Date Used in PTA Calculation Critical | 18 Aug, 2015 | US9107921 |
| Recordation of Patent Grant Mailed Critical | 18 Aug, 2015 | US9107921 |
| Email Notification Critical | 30 Jul, 2015 | US9107921 |
Chlorpheniramine Maleate; Codeine Phosphate's Family Patents
